News About: Pharm. Industry
Rapid increase of illegal rebates for past 3 years in various methods
While illegal drug rebates were rapidly increased for the past 3 years, there were also 16 companies exposed for illegal rebates for more than 3 times.
The highest number of times a single company was exposed for ill...
SK Chemicals acquires commercialization approval of world’s 2nd zoster vaccine ‘Sky Zoster’
A Korean pharmaceutical company is expected to widen options for patients using its excellent technology power in the world’s zoster vaccine market which has been monopolized by a global pharmaceutical company.
SK Ch...
Korea Pharmaceutical Ind. Coop’s Joint Testing Center opens
The Korea Pharmaceutical Ind. Coop.(Chairman Yong-Jun Cho, CEO of Dongkoo Bio&Pharma), announced acquisition of approval from the Ministry of Food and Drug Safety(MFDS) for the ‘Joint Testing Center’ that the company ...
Dong-A Socio, Alteogen & DMBio signs contract service agreement of macular degeneration treatment
Alteogen(CEO Soon-Jae Park), a company which are developing a biosimilar of macular degeneration treatment ‘Eylea,’ announced on the 28th that it signed a Eylea biosimilar manufacturing agreement with DMBio(Byung-Jo M...
Aprogen’s ‘Remicade’ biosimilar break into KRW 1 trillion Japanese market
A ‘Remicade’ biosimilar developed by Aprogen has made a stepping stone to enter the KRW 1 trillion Japanese market.
Aprogen(CEO Jae-Seop Kim), a biosimilar company, announced the company acquired approval of its Remi...
Celltrion selects ‘Oracle’ technology to smoothly manage drug side effects
Oracle announced on the 26th(U.S. local time) that Celltrion chose ‘Oracle Health Sciences Argus’ and ‘Oracle Health Sciences Empirica Signal’ to launch life-saving chronic disease treatments more and cheaper by contr...
KRW 1.9 trillion exports in 1st half of the year, increased by 6.9%
The 1st half of this year’s medicine exports were KRW 1.9 trillion, reaching KRW 2 trillion, and 106 listed pharmaceutical companies recorded KRW 8.3 trillion sales.
The Ministry of Health and Welfare(Minister Neung-...
C&R Research founds first Korea-China joint clinical CRO company in China
In order to provide clinical trial and approval services in China, C&R Research announced on the 21st it founded the first Korea-China joint CRO organization called ‘C&R-LEWEI JV (北京乐维创信医药科技有限公司)’ with Lewei in ...
Myungmoon acquires approval of its stomach and head & neck cancer treatment as ‘first generic’
Myungmoon Pharm, which has recently concentrated its capacity into the anticancer drug business, acquired approval of its stomach cancer and head & neck cancer treatments, ‘Tego Cap 20 and Tego Cap 25,’ from the Minis...
Jeil Pharmaceutical’s new diabetes type I drug development selected as MOHW’s project
‘JP -2266,’ a new oral diabetes type I drug being developed by Jeil Pharmaceutical(CEO/President Seok-Jae Sung), was selected as the Ministry of Health and Welfare’s high-tech medical technology development(new drug d...
